Beverly Green, MD, MPH, is a physician-scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow—and easier for providers to deliver.
Dr. Green’s research has a strong public health focus, targeting conditions that affect large proportions of the population, such as cardiovascular disease, cancer, and obesity. She also emphasizes leveraging technologies and systems-based care.
In 2016 Dr. Green launched the BP-CHECK study, which aims to find the easiest, most accurate way to diagnose high blood pressure. With a $2.8 million award from the Patient-Centered Outcomes Research Institute (PCORI), the study will compare blood pressure readings taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension.
Dr. Green’s previous research has shown that:
She is now working to translate similar innovative approaches to care into community settings through collaborations with the OCHIN Practice-Based Research Network and two large health insurance plans that provide Medicaid insurance to low-income individuals and families.
She is also a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is build relationships between researchers and community partners, conduct cancer-related research, and translate research into community practice.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was as an associate editor for the American Journal of Preventive Medicine from 2009 to 2014. She is an editorial board member of the Journal of the American Board of Family Practice. She is also a fellow of the American Heart Association, an honor given for contributions to the field. Dr. Green has served as an associate clinical professor at the UW School of Medicine since 1992.
Green BB, Vollmer WM, Keast E, Petrik AF, Coronado GD. Challenges in assessing population reach in a pragmatic trial. Prev Med Rep. 2019 May 29;15:100910. doi: 10.1016/j.pmedr.2019.100910. eCollection 2019. PubMed
Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Kimbel KJ, Kullgren JT, Meenan RT, Vernon SW. Financial incentives to increase colorectal cancer screening uptake and decrease disparities: a randomized clinical trial. JAMA Netw Open. 2019;2(7):e196570. doi: 10.1001/jamanetworkopen.2019.6570. PubMed
Green BB, Coronado GD, Schwartz M, Coury J, Baldwin LM. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice. Implement Sci. 2019 May 29;14(1):53. doi: 10.1186/s13012-019-0903-5. PubMed
Curtis LH, Dember LM, Vazquez MA, Murray D, DeBar L, Staman KL, Septimus E, Mor V, Volandes A, Wells BL, Huang SS, Green BB, Coronado G, Meyers CM, Tuzzio L, Hernandez AF, Sugarman J. Addressing guideline and policy changes during pragmatic clinical trials. Clin Trials. 2019 May 14:1740774519845682. doi: 10.1177/1740774519845682. [Epub ahead of print]. PubMed
Angier H, Huguet N, Marino M, Green B, Holderness H, Gold R, Hoopes M, DeVoe J. Observational study protocol for evaluating control of hypertension and the effects of social determinants. BMJ Open. 2019 Mar 15;9(3):e025975. doi: 10.1136/bmjopen-2018-025975. PubMed
Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.
Read about it in News and Events.
Dr. Beverly Green describes working with Kaiser Permanente Northwest to reduce cancer screening disparities.
Read it in Healthy Findings.
Our Survey Research Program reached out to nearly 55,000 Kaiser Permanente Washington members in 2017. Learn more about this small, skillful team.
ACP Internist, Jan 2019